2024 ECNP Congress
Events
Congresses
ECNP Courses
Workshop Neuropsychopharmacology
New Frontiers Meeting
Workshop Clinical Research Methods
ECNP-PsychX talks
Early Career
Workshop Neuropsychopharmacology
Definition Early Career Scientist
Workshop Clinical Research Methods
Opportunities Early Career Scientists
Research Internship
Job postings
Awards
Neuropsychopharmacology online course
Early Career Advisory Panel
Research & Innovation
ECNP Courses
New Frontiers Meeting
Journals
Neuroscience-based Nomenclature (NbN)
Awards
ECNP Networks and TWGs
ECNP as dissemination partner in EU projects
News
Agenda
Podcast series
Top article picks
Press office
Ukraine crisis
Reports
Newsletters
Message of the President
Expert Talks
Webcasts
ECNP in depth: interviews
Corona watch
About
Our aims and objectives
Policy and advocacy
Membership
ECNP history
How we are organised
ECNP vacancies
Governance
My ECNP
My ECNP
ECNP
Research & Innovation
ECNP Networks and TWGs
List of ECNP Networks and TWGs
iPSCs Platform for Neuropsychiatry
Output
Previous seminars
> Logout
> Logout
Members
Output
Previous seminars
Previous virtual seminar series
Past dates
Wednesday 18 October at 16.00 CEST
Programme is hosted by the group of Ágota Apáti and János Réthelyi and it includes two talks:
1) "Transcriptomic comparison of schizophrenia patient-derived iPSC-based hippocampal neurons and CRISPR modified isogenic controls" with Csongor Tordai, Hungary
2) "Effects of metformin on neurite outgrowth and proliferation in neuronal stem cells derived from DM Type2 patients and healthy controls" with Katalin Vincze, Hungary
16 August at 16.00 CEST (Central European Summer Time)
Karo Talvio, Finland and Maija L Castren, Finland
'Human fragile X iPSC-derived cells modeling mechanisms affected in neuropsychiatric disorders'
28 June 2023 at 16.00 CEST (Central European Summer Time)
Programme was hosted by the group of Tanja Sheldrick-Michel.
'Using cerebral organoids for studying psychiatric disorders: progress and challenges'.
26 April 2023 at 16.00 CEST (Central European Summer Time)
Programme was hosted by the group of Luigia Ginetta Collo and it included two talks:
1) 'Structural plasticity induced by ketamine in human dopaminergic neurons as mechanism relevant for treatment-resistant depression' by Laura Cavalleri, Italy
2) 'Multiple system atrophy iPSC-derived neurons reveal structural and functional differences from controls' by Giulia Sofia Marcotto, Italy
8 March 2023 at 16.00 CET (Central European Time)
Programme was hosted by the group of Jeroen Pasterkamp.
Suzy Varderidou gave a presentation entitled: ‘Amyotrophic Lateral Sclerosis (ALS) propagation through Extracellular Vesicles and treatment strategies.‘
22 February 2023 at 16.00 CET (Central European Time)
Programme was hosted by the group of Edna Grünblatt.
Two researchers, Cristine Marie Yde Ohki and Natalie Monet Walter, gave a presentation entitled: 'Investigating the cellular and molecular role of Wnt-pathway across neurodevelopmental processes in health and ADHD- possible modulation via methylphenidate or PUFAs'
14 December 2022 at 16.00 CET (Central European Time)
Programme hosted by the group of Armida Mucci
‘Innovative cellular models for schizophrenia: current findings and future approaches’
26 October 2022 at 16.00 CEST
(Central European Summer Time)
Programme hosted by the Harwood Group had three talks:
1) 'Effects of the dietary n-6 PUFAs on human neuronal function' by Karolina Dec, United Kingdom
2) 'Investigating TSC function with an inducible Cas13' by Laura Kleckner, United Kingdom
3) 'Kleefstra syndrome and miRNA regulation of NRSF/REST' by Jamie Wood, United Kingdom
31 August 2022 at 16.00 CEST
(Central European Summer Time)
The seminar, hosted by Deepak Srivastav's group, had two talks:
1) 'Analysing early neuronal differentiation in patient-derived induced pluripotent stem cells (iPSC) with NRXN1 mutations' by Lucia Dutan Polit, United Kingdom
2) 'Translating genetic susceptibility to neurobiology of disease — understanding the role of psychosis risk candidate ZNF804A during synaptic development' by Laura Sichlinger, United Kingdom
1 June 2022
The research group of Oliver Brüstle, Germany, gave two talks on the use of forward-programmed neurons to model candidate genes for neuropsychiatric diseases:
1) Programmed neuronal subtypes for modeling neuropsychiatric disorders by Michael Peitz
2) Generation of an isogenic human model of SYNGAP1 syndrome by Christina Au Yeung